Kathleen D. Scott Silverback Therapeutics, Inc. (SBTX) insider trading activity

SBTX Quotes by TradingView

Kathleen D. Scott is Chief Financial Officer of Silverback Therapeutics, Inc.. Currently has a direct ownership of 4,949 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on Oct 16, 2024, when has been sold 12,500 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $200,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.95K
62.5% 3M change
n/a 12M change
Total Value Held $0

Kathleen D. Scott Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 16 2024
SELL
Open market or private sale
$200,000 $16.0 p/Share
12,500 Reduced 71.64%
4,949 Common Stock
Oct 16 2024
BUY
Exercise of conversion of derivative security
$18,750 $1.5 p/Share
12,500 Added 41.74%
17,449 Common Stock
Aug 20 2024
SELL
Open market or private sale
$200,000 $16.0 p/Share
12,500 Reduced 48.64%
13,199 Common Stock
Aug 20 2024
BUY
Exercise of conversion of derivative security
$18,750 $1.5 p/Share
12,500 Added 32.72%
25,699 Common Stock

Also insider at

DRMA
Dermata Therapeutics, Inc. Healthcare
GFOR-WT
Graf Acquisition Corp. IV
Director
KDS

Kathleen D. Scott

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SBTX